A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen

NCT02963103 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
13
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision to terminate the study because subject enrollment was difficult.

Conditions

Interventions

Sponsor

Astellas Pharma Korea, Inc.